Aatmaj Healthcare Limited (NSE:AATMAJ)
India · Delayed Price · Currency is INR 22.10
+0.60 (2.79%)
Oct 22, 2026, 3:29 PM IST
Aatmaj Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 243.18 | 195.33 | 157.38 | 271.63 | 218.09 | |
Revenue Growth | 24.49% | 24.12% | -42.06% | 24.55% | - |
Cost of Revenue | 84.59 | 80.37 | 61.58 | 66.07 | 79.62 |
Gross Profit | 158.59 | 114.96 | 95.8 | 205.56 | 138.47 |
Selling, General & Admin | 13.54 | 14.18 | 6.72 | 1.7 | - |
Other Operating Expenses | 121.24 | 84.22 | 62.65 | 105.29 | 63.25 |
Operating Expenses | 144.51 | 107.61 | 77.46 | 113.87 | 67.6 |
Operating Income | 14.09 | 7.35 | 18.34 | 91.69 | 70.88 |
Interest Expense | -11.53 | -8.29 | -11.65 | -7.84 | -1.16 |
Interest & Investment Income | 9.55 | 12.19 | 7.58 | - | - |
Other Non Operating Income (Expenses) | -2.22 | -0.54 | -0.84 | -1.12 | -1.26 |
EBT Excluding Unusual Items | 9.89 | 10.71 | 13.43 | 82.74 | 68.46 |
Gain (Loss) on Sale of Assets | -0.2 | - | - | - | - |
Other Unusual Items | 0.04 | - | - | - | - |
Pretax Income | 9.74 | 10.71 | 13.43 | 82.74 | 68.46 |
Income Tax Expense | 2.6 | 4.32 | 4.62 | 23.67 | 19.25 |
Net Income | 7.13 | 6.39 | 8.81 | 59.07 | 49.21 |
Net Income to Common | 7.13 | 6.39 | 8.81 | 59.07 | 49.21 |
Net Income Growth | 11.58% | -27.42% | -85.09% | 20.03% | - |
Shares Outstanding (Basic) | 23 | 23 | 23 | 16 | 11 |
Shares Outstanding (Diluted) | 23 | 23 | 23 | 16 | 11 |
Shares Change | - | - | 39.51% | 50.00% | - |
EPS (Basic) | 0.32 | 0.28 | 0.39 | 3.65 | 4.56 |
EPS (Diluted) | 0.32 | 0.28 | 0.39 | 3.65 | 4.55 |
EPS Growth | 11.58% | -27.42% | -89.31% | -19.96% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -54.7 | 25.97 | -158.23 | 43.45 | -8.54 |
Free Cash Flow Per Share | -2.42 | 1.15 | -7.00 | 2.68 | -0.79 |
Dividend Per Share | - | - | 0.050 | - | - |
Dividend Growth | - | - | - | - | - |
Gross Margin | 65.22% | 58.85% | 60.87% | 75.68% | 63.49% |
Operating Margin | 5.79% | 3.76% | 11.65% | 33.76% | 32.50% |
Profit Margin | 2.93% | 3.27% | 5.60% | 21.75% | 22.56% |
Free Cash Flow Margin | -22.49% | 13.30% | -100.54% | 16.00% | -3.92% |
EBITDA | 23.6 | 16.35 | 26.2 | 98.32 | 75.09 |
EBITDA Margin | 9.70% | 8.37% | 16.64% | 36.20% | 34.43% |
D&A For EBITDA | 9.51 | 9 | 7.86 | 6.63 | 4.21 |
EBIT | 14.09 | 7.35 | 18.34 | 91.69 | 70.88 |
EBIT Margin | 5.79% | 3.76% | 11.65% | 33.76% | 32.50% |
Effective Tax Rate | 26.74% | 40.30% | 34.40% | 28.61% | 28.12% |
Revenue as Reported | 252.73 | 208.5 | 165.85 | 271.89 | 218.09 |